IORT is used to treat a variety of solid tumor cancers. More than 15,000 patients have received IORT as part of their cancer treatment. The Information for Physicians page provides a list the most common sites for IORT treatment. Whether a particular cancer will benefit from IORT treatment will depend on several factors, including, but not limited to, the stage of the tumor, the tumor resectability, the extent of the disease, and any previous treatment which may have been received. For any particular tumor, it is essential to discuss the merits of including IORT as part of the cancer treatment program with a experienced oncologist . A partial list of centers in the United States that have IORT treatment capability can be obtained by clicking on “Find a Mobetron near you”, below.
-
Recent News
- Fourth German Hospital Selects IntraOp Medical Corporation’s Mobetron
- IntraOp Medical wins Patent Defense Suit Protecting Their Intellectual Property
- Third German Hospital Selects IntraOp Medical Corporation’s Mobetron
- IntraOp Medical Corporation Brings Together Top Minds in IOERT for Scholarly Exchange
- Italian Cancer Center, Ospedali Riuniti, Chooses IntraOp Medical’s Mobetron for Advanced Cancer Care

